they would go public, say somewhere between 13.00 and 20.00, and try to get the shareholders to vote in favor of it, because everybody knows the CEO would reject it, because he would probably lose his job.
tysabri is the cash cow for elan. they have a partner with this drug and a agreement if either biib or elan are bought out that the drug would revert to the other party. either pfe buys both elan and biib out or they would need approval from biib about tysabri. i strongly doubt this deal can happen. jmho-bucko